Chile vs Mongolia: Treatment success rate for patients treated for MDR-TB
Chile
64.0%
in 2022
Mongolia
65.0%
in 2022
Chile rank
116th
Mongolia rank
113th
Treatment success rate for patients treated for MDR-TB over time
- Chile
- Mongolia
How they compare
Mongolia currently reports 65.0% against 64.0% in Chile, a difference of 1.0%.
The two have swapped places 2 times across 17 shared years of data; in 2006 it was Mongolia ahead.
Chile ranks 116th and Mongolia ranks 113th of 163 countries.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.0% | 73.8% | 42.8% | Mongolia |
| 2010s | 45.2% | 63.8% | 18.6% | Mongolia |
| 2020s | 59.0% | 72.0% | 13.0% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Chile or Mongolia?
- Mongolia, at 65.0% against 64.0% in Chile as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Chile and Mongolia?
- 1.0%, with Mongolia ahead.
- How many years of comparable data are there for Chile and Mongolia?
- 17 years are reported by both, from 2006 to 2022.
- How do Chile and Mongolia rank globally for treatment success rate for patients treated for mdr-tb?
- Chile ranks 116th and Mongolia ranks 113th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.